CAMBRIDGE, Mass., April 03, 2025--(BUSINESS WIRE)--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

Dear Customers, Researchers and Friends of Vizgen: On February 5th, we secured an important settlement putting an end to litigation, including cases in the U.S. and Europe, with 10X Genomics and ...

Spatial transcriptomics technologies opened the door for new kinds of biological measurements, allowing scientists to generate detailed maps of where genes are expressed in tissue. But most methods ...

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

Scale Biosciences, Inc. (Scale Bio), a leader in highly scalable single cell technologies, today announced its participation in the Chan Zuckerberg Initiative's (CZI) Billion Cells Project at the Chan ...

Hu then used an algorithm commonly used in single-cell analysis called Uniform Manifold Approximation and Projection (UMAP) to reconstruct the beads' original locations on the slide. When the ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

Now, though, Nvidia, which designed the console's GPU, has talked a little about Switch 2's abilities, claiming it has "10x the graphics performance" of the original Switch. Nvidia discussed ...